The authors missed to include the following funding information – ‘This research received “Ricerca Corrente 2024” funding from the Italian Ministry of Health to cover publication costs (CDC 099183)’ in the article. The authors would like to apologise for any inconvenience caused.
Corrigendum to “PARP inhibitors in gliomas: Mechanisms of action, current trends and future perspectives” [Cancer Treat. Rev. 131 (2024) 102850] (Cancer Treatment Reviews (2024) 131, (S0305737224001798), (10.1016/j.ctrv.2024.102850))
Cerretti G.;
2025-01-01
Abstract
The authors missed to include the following funding information – ‘This research received “Ricerca Corrente 2024” funding from the Italian Ministry of Health to cover publication costs (CDC 099183)’ in the article. The authors would like to apologise for any inconvenience caused.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
